Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhalable Hydroxychloroquine for COVID-19
NCT04477083Unknown
- Sponsor
- Mansoura University
- Start
- Jul 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Mansoura University. Primary endpoints: Time to clinical recovery at 15 days and Time to achieve viral clearance state at 15 days. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04477083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04477083.